Physician profile
Marco Duran
NPI 1043605066
$15,351.35
in general payments reported to CMS, 2019-2025
27 companies · $1,134 in 2025
The $1,134 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $550 · 2020: $542 · 2021: $1,014 · 2022: $4,922 · 2023: $2,649 · 2024: $4,540 · 2025: $1,134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,062 · Travel and Lodging: $223 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $37.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,062.28 |
| Travel and Lodging | $223.48 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $37.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,442.91 | 2019-2025 | Eterna, Proclaim |
| Nalu Medical, INC. | $3,108.84 | 2023-2025 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $2,016.44 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Spinal Simplicity, LLC | $1,265.74 | 2022-2025 | Ha Minuteman G3-R |
| Nevro Corp. | $918.36 | 2020-2024 | Senza |
| Vertos Medical, INC. | $828.12 | 2022-2024 | Mild Device Kit |
| Saluda Medical Americas, INC. | $366.73 | 2023-2025 | Evoke, Evoke Scs |
| Collegium Pharmaceutical, INC. | $351.84 | 2020-2023 | Xtampza, Belbuca |
| Spr Therapeutics, INC | $235.32 | 2022-2023 | Sprint Pns System |
| Globus Medical, INC. | $118.46 | 2025 | Senza |
| Relievant Medsystems, INC. | $107.95 | 2020 | |
| Painteq LLC | $107.09 | 2022 | |
| Pacira Therapeutics, INC. | $69.17 | 2021 | |
| Radius Health, INC. | $50.59 | 2022 | |
| Medtronic USA, INC. | $48.48 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $40.37 | 2024 | Ivas |
| Biodelivery Sciences International, INC. | $40.20 | 2020-2021 | |
| Becton, Dickinson and Company | $37.00 | 2024 | |
| Arbor Pharmaceuticals, INC. | $35.72 | 2021 | |
| Avanos Medical | $34.48 | 2023-2024 | Generator |
| Acacia Pharma INC | $30.99 | 2021-2022 | |
| Valinor Pharma, LLC | $19.53 | 2023 | Movantik |
| Averitas Pharma INC. | $16.55 | 2023 | Qutenza |
| Abbvie INC. | $16.39 | 2025 | |
| Grt US Holding, INC. | $15.16 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $14.86 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.06 | 2023 | Relistor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marco Duran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.